pirfenidone has been researched along with Idiopathic Inflammatory Myopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fares, N; Habr, B; Hajal, J; Layoun, H; Saliba, Y; Smayra, V | 1 |
1 other study(ies) available for pirfenidone and Idiopathic Inflammatory Myopathies
| Article | Year |
|---|---|
Pirfenidone mitigates TGF-β1-mediated fibrosis in an idiopathic inflammatory myositis-associated interstitial lung disease model.
Topics: Animals; Guinea Pigs; Lung; Lung Diseases, Interstitial; Male; Mice; Myositis; Pulmonary Fibrosis; Pyridones; Transforming Growth Factor beta1 | 2022 |